Clinical trial
IC14 Antibodies to Treat Individuals With Acute Lung Injury
NCT00233207 · University of Washington, Other · Terminated
Key facts
| NCT number | NCT00233207 |
|---|---|
| Title | IC14 Antibodies to Treat Individuals With Acute Lung Injury |
| Official title | Acute Lung Injury Clinical Trials Incubator Unit |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Adult, Lung Diseases |
| Intervention type | Drug |
| Interventions | IC14 |
| Enrollment | 13 |
| Start date | Sep 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Oct 5, 2005 |
| Last update posted | May 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: